Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18452-18457
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18452
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18452
Table 1 Patient characteristics n (%)
| Unresectable(n = 55) | Recurrent(n = 10) | P value | |
| Age (median, range) | 68 (47-83) | 70 (51-79) | 0.43 |
| Sex (male / female) | 31/24 | 7/3 | 0.42 |
| ECOG performance status | 0.76 | ||
| 0 | 28 (51) | 6 (60) | |
| 1 | 25 (45) | 4 (40) | |
| 2-3 | 2 (4) | 0 | |
| Primary biliary site | 0.07 | ||
| Gallbladder | 26 (47) | 4 (40) | |
| Intrahepatic bile duct | 20 (36) | 2 (20) | |
| Extrahepatic bile duct | 9 (16) | 3 (30) | |
| Ampulla of Vater | 0 | 1 (10) | |
| Baseline sum of longest diameter(median, range, cm) | 9 (1.0-31.9) | 2.8 (1.2-16.0) | 0.04 |
- Citation: Sasaki T, Isayama H, Nakai Y, Ito Y, Yasuda I, Toda N, Yagioka H, Matsubara S, Hanada K, Maguchi H, Kamada H, Hasebe O, Mukai T, Okabe Y, Maetani I, Koike K. Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer. World J Gastroenterol 2014; 20(48): 18452-18457
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18452.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18452